 | • レポートコード：QYR9ST04694 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、アルツハイマー病治療薬の世界市場について調査・分析し、アルツハイマー病治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（バイオマーカー、コリンエステラーゼ阻害剤、NMDA受容体拮抗薬）、用途別（病院、診療所）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のアルツハイマー病治療薬市場動向 ・主要企業別マーケットシェア ・アルツハイマー病治療薬の種類別市場規模2014-2019 （バイオマーカー、コリンエステラーゼ阻害剤、NMDA受容体拮抗薬） ・アルツハイマー病治療薬の用途別市場規模2014-2019 （病院、診療所） ・アルツハイマー病治療薬の北米市場：主要企業・種類別/用途別市場規模 ・アルツハイマー病治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・アルツハイマー病治療薬の中国市場：主要企業・種類別/用途別市場規模 ・アルツハイマー病治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・アルツハイマー病治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・アルツハイマー病治療薬のインド市場：主要企業・種類別/用途別市場規模 ・アルツハイマー病治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （F. Hoffmann-La Roche、Merck、Pfizer、Novartis、Eisai、Actavis、Daiichi Sankyo） ・アルツハイマー病治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are memory loss, insomnia, repetitive movements, agitation, anxiety, depression and loss of reasoning abilities. All memory and mental functioning may be lost in advanced stages of the disease. Alzheimer’s disease may lead to death. According to National Institute of Aging, Alzheimer’s disease is the common form of dementia. Population aging across the globe is a major factor driving the market for Alzheimer’s therapeutics and diagnostics. Rising life expectancy is contributing to quick increases in number of aged population, and is associated with increased prevalence of chronic diseases like dementia. Therapies for AD offer temporary and uncertain improvements in the well-being of individuals, and none of the approved drugs can modify the course of the disease advancement. Thus, the magnitude of the affected population and lack of suitable and effective treatment offers an incredible opportunity for drug manufacturers. However, identification of the primary reasons and mechanisms involved in AD are is limited. Drug manufacturers have been unable to validate significant clinical benefits of treatment for a numerous of new compounds due to strict regulations. One of the significant trend observed in this market is collaboration of the existing players. Precisely, diagnostic technology companies are carefully trying to bring about effective biomarker technologies to support and improve the drug development process for potential drug candidates which is further expected to propel the demand.
North America dominates the global market for alzheimer’s disease therapeutics due to large number of aging population. Asia followed by the Europe are expected to show high growth rates in the next five years in the global alzheimer’s disease therapeutics market. China and India are expected to be the fastest growing alzheimer’s disease therapeutics markets in Asia-Pacific region. Some of the key driving forces for alzheimer’s disease therapeutics market in emerging countries are increasing R&D investment, large pool of patients and improvement of healthcare infrastructure.
In 2018, the global Alzheimers Disease Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Alzheimers Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alzheimers Disease Therapeutics development in United States, Europe and China.
The key players covered in this study
F. Hoffmann-La Roche
Merck
Pfizer
Novartis
Eisai
Actavis
Daiichi Sankyo
…
Market segment by Type, the product can be split into
Biomarkers
Cholinesterase Inhibitors
NMDA Receptor Antagonists
Market segment by Application, split into
Hospitals
Clinics
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Alzheimers Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Alzheimers Disease Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Alzheimers Disease Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Alzheimers Disease Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Biomarkers
1.4.3 Cholinesterase Inhibitors
1.4.4 NMDA Receptor Antagonists
1.5 Market by Application
1.5.1 Global Alzheimers Disease Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Alzheimers Disease Therapeutics Market Size
2.2 Alzheimers Disease Therapeutics Growth Trends by Regions
2.2.1 Alzheimers Disease Therapeutics Market Size by Regions (2014-2025)
2.2.2 Alzheimers Disease Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Alzheimers Disease Therapeutics Market Size by Manufacturers
3.1.1 Global Alzheimers Disease Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Alzheimers Disease Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Alzheimers Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Alzheimers Disease Therapeutics Key Players Head office and Area Served
3.3 Key Players Alzheimers Disease Therapeutics Product/Solution/Service
3.4 Date of Enter into Alzheimers Disease Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Alzheimers Disease Therapeutics Market Size by Type (2014-2019)
4.2 Global Alzheimers Disease Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Alzheimers Disease Therapeutics Market Size (2014-2019)
5.2 Alzheimers Disease Therapeutics Key Players in United States
5.3 United States Alzheimers Disease Therapeutics Market Size by Type
5.4 United States Alzheimers Disease Therapeutics Market Size by Application
6 Europe
6.1 Europe Alzheimers Disease Therapeutics Market Size (2014-2019)
6.2 Alzheimers Disease Therapeutics Key Players in Europe
6.3 Europe Alzheimers Disease Therapeutics Market Size by Type
6.4 Europe Alzheimers Disease Therapeutics Market Size by Application
7 China
7.1 China Alzheimers Disease Therapeutics Market Size (2014-2019)
7.2 Alzheimers Disease Therapeutics Key Players in China
7.3 China Alzheimers Disease Therapeutics Market Size by Type
7.4 China Alzheimers Disease Therapeutics Market Size by Application
8 Japan
8.1 Japan Alzheimers Disease Therapeutics Market Size (2014-2019)
8.2 Alzheimers Disease Therapeutics Key Players in Japan
8.3 Japan Alzheimers Disease Therapeutics Market Size by Type
8.4 Japan Alzheimers Disease Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Alzheimers Disease Therapeutics Market Size (2014-2019)
9.2 Alzheimers Disease Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Alzheimers Disease Therapeutics Market Size by Type
9.4 Southeast Asia Alzheimers Disease Therapeutics Market Size by Application
10 India
10.1 India Alzheimers Disease Therapeutics Market Size (2014-2019)
10.2 Alzheimers Disease Therapeutics Key Players in India
10.3 India Alzheimers Disease Therapeutics Market Size by Type
10.4 India Alzheimers Disease Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Alzheimers Disease Therapeutics Market Size (2014-2019)
11.2 Alzheimers Disease Therapeutics Key Players in Central & South America
11.3 Central & South America Alzheimers Disease Therapeutics Market Size by Type
11.4 Central & South America Alzheimers Disease Therapeutics Market Size by Application
12 International Players Profiles
12.1 F. Hoffmann-La Roche
12.1.1 F. Hoffmann-La Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Alzheimers Disease Therapeutics Introduction
12.1.4 F. Hoffmann-La Roche Revenue in Alzheimers Disease Therapeutics Business (2014-2019)
12.1.5 F. Hoffmann-La Roche Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Alzheimers Disease Therapeutics Introduction
12.2.4 Merck Revenue in Alzheimers Disease Therapeutics Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Alzheimers Disease Therapeutics Introduction
12.3.4 Pfizer Revenue in Alzheimers Disease Therapeutics Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Alzheimers Disease Therapeutics Introduction
12.4.4 Novartis Revenue in Alzheimers Disease Therapeutics Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Eisai
12.5.1 Eisai Company Details
12.5.2 Company Description and Business Overview
12.5.3 Alzheimers Disease Therapeutics Introduction
12.5.4 Eisai Revenue in Alzheimers Disease Therapeutics Business (2014-2019)
12.5.5 Eisai Recent Development
12.6 Actavis
12.6.1 Actavis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Alzheimers Disease Therapeutics Introduction
12.6.4 Actavis Revenue in Alzheimers Disease Therapeutics Business (2014-2019)
12.6.5 Actavis Recent Development
12.7 Daiichi Sankyo
12.7.1 Daiichi Sankyo Company Details
12.7.2 Company Description and Business Overview
12.7.3 Alzheimers Disease Therapeutics Introduction
12.7.4 Daiichi Sankyo Revenue in Alzheimers Disease Therapeutics Business (2014-2019)
12.7.5 Daiichi Sankyo Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Alzheimers Disease Therapeutics Key Market Segments
Table Key Players Alzheimers Disease Therapeutics Covered
Table Global Alzheimers Disease Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Alzheimers Disease Therapeutics Market Size Market Share by Type 2014-2025
Figure Biomarkers Figures
Table Key Players of Biomarkers
Figure Cholinesterase Inhibitors Figures
Table Key Players of Cholinesterase Inhibitors
Figure NMDA Receptor Antagonists Figures
Table Key Players of NMDA Receptor Antagonists
Table Global Alzheimers Disease Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Alzheimers Disease Therapeutics Report Years Considered
Table Global Alzheimers Disease Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Alzheimers Disease Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Alzheimers Disease Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Alzheimers Disease Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Alzheimers Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Alzheimers Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Alzheimers Disease Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Alzheimers Disease Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Alzheimers Disease Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Alzheimers Disease Therapeutics Market Share by Manufacturers in 2018
Table Global Alzheimers Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Alzheimers Disease Therapeutics Product/Solution/Service
Table Date of Enter into Alzheimers Disease Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Alzheimers Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Alzheimers Disease Therapeutics Market Size Share by Type (2014-2019)
Figure Global Alzheimers Disease Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Alzheimers Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Alzheimers Disease Therapeutics Market Size Share by Application (2014-2019)
Figure Global Alzheimers Disease Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Alzheimers Disease Therapeutics Revenue Market Share by Application in 2018
Figure United States Alzheimers Disease Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Alzheimers Disease Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Alzheimers Disease Therapeutics Market Share (2018-2019)
Table United States Alzheimers Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Alzheimers Disease Therapeutics Market Share by Type (2014-2019)
Table United States Alzheimers Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Alzheimers Disease Therapeutics Market Share by Application (2014-2019)
Figure Europe Alzheimers Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Alzheimers Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Alzheimers Disease Therapeutics Market Share (2018-2019)
Table Europe Alzheimers Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Alzheimers Disease Therapeutics Market Share by Type (2014-2019)
Table Europe Alzheimers Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Alzheimers Disease Therapeutics Market Share by Application (2014-2019)
Figure China Alzheimers Disease Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Alzheimers Disease Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Alzheimers Disease Therapeutics Market Share (2018-2019)
Table China Alzheimers Disease Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Alzheimers Disease Therapeutics Market Share by Type (2014-2019)
Table China Alzheimers Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Alzheimers Disease Therapeutics Market Share by Application (2014-2019)
Figure Japan Alzheimers Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Alzheimers Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Alzheimers Disease Therapeutics Market Share (2018-2019)
Table Japan Alzheimers Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Alzheimers Disease Therapeutics Market Share by Type (2014-2019)
Table Japan Alzheimers Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Alzheimers Disease Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Alzheimers Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Alzheimers Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Alzheimers Disease Therapeutics Market Share (2018-2019)
Table Southeast Asia Alzheimers Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Alzheimers Disease Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Alzheimers Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Alzheimers Disease Therapeutics Market Share by Application (2014-2019)
Figure India Alzheimers Disease Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Alzheimers Disease Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Alzheimers Disease Therapeutics Market Share (2018-2019)
Table India Alzheimers Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Alzheimers Disease Therapeutics Market Share by Type (2014-2019)
Table India Alzheimers Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Alzheimers Disease Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Alzheimers Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Alzheimers Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Alzheimers Disease Therapeutics Market Share (2018-2019)
Table Central & South America Alzheimers Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Alzheimers Disease Therapeutics Market Share by Type (2014-2019)
Table Central & South America Alzheimers Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Alzheimers Disease Therapeutics Market Share by Application (2014-2019)
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Alzheimers Disease Therapeutics Business (2014-2019) (Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Merck Company Details
Table Merck Revenue in Alzheimers Disease Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Alzheimers Disease Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Alzheimers Disease Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Eisai Company Details
Table Eisai Revenue in Alzheimers Disease Therapeutics Business (2014-2019)(Million US$)
Figure Eisai Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2014-2019)
Table Eisai Recent Development
Table Actavis Company Details
Table Actavis Revenue in Alzheimers Disease Therapeutics Business (2014-2019)(Million US$)
Figure Actavis Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2014-2019)
Table Actavis Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Revenue in Alzheimers Disease Therapeutics Business (2014-2019)(Million US$)
Figure Daiichi Sankyo Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2014-2019)
Table Daiichi Sankyo Recent Development
Table Global Alzheimers Disease Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Alzheimers Disease Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Alzheimers Disease Therapeutics Market Size Share by Regions in 2025
Figure United States Alzheimers Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Alzheimers Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Alzheimers Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Alzheimers Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Alzheimers Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Alzheimers Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Alzheimers Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Alzheimers Disease Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Alzheimers Disease Therapeutics Market Size by Product (2019-2025)
Figure Global Alzheimers Disease Therapeutics Market Size by Product in 2025
Table Global Alzheimers Disease Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Alzheimers Disease Therapeutics Market Size by Application (2019-2025)
Figure Global Alzheimers Disease Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
冠動脈疾患治療薬の世界市場：市場規模・現状・予測 Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death.Our research analysis on the global coronary artery disease therapeutics market has identified that …- 非アルコール性脂肪性肝疾患治療薬の世界市場：市場規模・現状・予測 Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …
- 末梢動脈疾患（PAD）治療薬の世界市場：市場規模・現状・予測 Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the…
- 感染症治療の世界市場：市場規模・現状・予測 Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them.Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of inf…
- 鎌状赤血球病治療法の世界市場：インサイト・予測 Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. People with this disorderhave atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape…